These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1715202)

  • 21. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical panel for the identification of malignant cells in serous effusions.
    Nance KV; Silverman JF
    Am J Clin Pathol; 1991 Jun; 95(6):867-74. PubMed ID: 1710419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis.
    Dejmek A; Hjerpe A
    Cytopathology; 2000 Feb; 11(1):8-17. PubMed ID: 10714371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
    Delahaye M; Hoogsteden HC; Van der Kwast TH
    J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
    Ghosh AK; Butler EB
    J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions.
    Silverman JF; Nance K; Phillips B; Norris HT
    Diagn Cytopathol; 1987 Jun; 3(2):134-40. PubMed ID: 2439266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.
    Ferrandez-Izquierdo A; Navarro-Fos S; Gonzalez-Devesa M; Gil-Benso R; Llombart-Bosch A
    Diagn Cytopathol; 1994; 10(3):256-62. PubMed ID: 7519540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytological study of serous effusions with the aid of tumour markers.
    Ray K; Mittal S; Gupta H; Jain M
    J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diagnostic technique for rapid fluorescence immunocytochemical staining of adenocarcinoma and mesothelial cells using liquid-based cytology.
    Morimoto A; Ito A; Hashimoto K; Nakano A; Nagasaka T; Yokoi T
    Acta Cytol; 2014; 58(5):461-8. PubMed ID: 25358455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions.
    Agarwal C; Jain M
    Indian J Pathol Microbiol; 2009; 52(1):25-8. PubMed ID: 19136774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay.
    Lawniczak M; Sikora J; Kania P; Zeromski J
    Lung; 1992; 170(2):65-74. PubMed ID: 1501508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.